Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance

Author:

Harigai Masayoshi1,Ishiguro Naoki2,Inokuma Shigeko3,Mimori Tsuneyo4,Ryu Junnosuke5,Takei Syuji6,Takeuchi Tsutomu7,Tanaka Yoshiya8,Takasaki Yoshinari9,Yamanaka Hisashi1,Yoshizawa Yuri10,Chinen Ichino10,Nakao Toru10,Koike Takao11

Affiliation:

1. Division of Epidemiology and Pharmacoepidemiology, Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan;

2. Graduate School & Faculty of Medicine, Nagoya University School of Medicine, Nagoya, Japan;

3. Chiba Central Medical Center, Chiba, Japan;

4. Kyoto University Graduate School of Medicine, Kyoto, Japan;

5. Nihon University School of Medicine, Tokyo, Japan;

6. Faculty of Medicine, Kagoshima University School of Health Science, Kagoshima, Japan;

7. Keio University School of Medicine, Tokyo, Japan;

8. University of Occupational and Environmental Health, Fukuoka, Japan;

9. Juntendo University School of Medicine, Tokyo, Japan;

10. Bristol-Myers Squibb K.K., Tokyo, Japan;

11. Sapporo Medical Center NTT EC, Sapporo, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Reference27 articles.

1. Statistics Bureau. Ministry of Internal Affairs and Communications Japan. Statistical Handbook of Japan 2015. http://www.stat.go.jp/english/data/handbook/pdf/2015all.pdf (accessed 26 Feb 2018).

2. Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis

3. Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3